J. David Haddox, DDS, MD, describes the most common method of opioid abuse.
Menin Inhibitors in AML: Frequently Asked QuestionsByAlexandra Gerlach, Content ProducerJune 29th 2026
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS ByMaria S. Charbonneau, PharmDJune 29th 2026
FDA Approves Veligrotug-vvze as First Agent With Data in Both Active and Chronic Thyroid Eye DiseaseByLuke Halpern, Associate EditorJune 29th 2026
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert SaysByAnnie Lambert, PharmD, BCSCP,Luke Halpern, Associate EditorJune 29th 2026